Literature DB >> 22724458

Mesoporous silica nanoparticles in nanotechnology.

Dennis Douroumis1, Ichioma Onyesom, Mohammed Maniruzzaman, John Mitchell.   

Abstract

Mesoporous silica nanoparticles (MSNs) are a versatile drug delivery system that can be used for loading of different guest molecules such as peptides, proteins, anticancer agents, and genetic material. MSNs are considered promising drug carriers due to their tuneable particle size, pore structure, and surface functionalization. Thus, MSNs provide opportunities for their effective application in a wide variety of fields. In the current review, we discuss both conventional and advanced MSNs synthesis methods, including their applications for drug delivery, gatekeepers, and biosensors. In addition, the research progress in biocompatibility, cytotoxicity, and internalization mechanisms is reported.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22724458     DOI: 10.3109/07388551.2012.685860

Source DB:  PubMed          Journal:  Crit Rev Biotechnol        ISSN: 0738-8551            Impact factor:   8.429


  13 in total

1.  Influence of Critical Parameters on Cytotoxicity Induced by Mesoporous Silica Nanoparticles.

Authors:  Amirsadra Ahmadi; Moses Sokunbi; Trisha Patel; Ming-Wei Chang; Zeeshan Ahmad; Neenu Singh
Journal:  Nanomaterials (Basel)       Date:  2022-06-11       Impact factor: 5.719

2.  Cellular Endocytosis and Trafficking of Cholera Toxin B-Modified Mesoporous Silica Nanoparticles.

Authors:  William A Walker; Mubin Tarannum; Juan L Vivero-Escoto
Journal:  J Mater Chem B       Date:  2016-01-07       Impact factor: 6.331

3.  Aerosol droplet delivery of mesoporous silica nanoparticles: A strategy for respiratory-based therapeutics.

Authors:  Xueting Li; Min Xue; Otto G Raabe; Holly L Aaron; Ellen A Eisen; James E Evans; Fred A Hayes; Sumire Inaga; Abderrahmane Tagmount; Minoru Takeuchi; Chris Vulpe; Jeffrey I Zink; Subhash H Risbud; Kent E Pinkerton
Journal:  Nanomedicine       Date:  2015-03-25       Impact factor: 5.307

4.  Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells.

Authors:  Jie Lu; Kohei Yoshimura; Koichi Goto; Craig Lee; Ken Hamura; Ohyun Kwon; Fuyuhiko Tamanoi
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

5.  Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging.

Authors:  Sihan Xue; Yao Wang; Mengxing Wang; Lu Zhang; Xiaoxia Du; Hongchen Gu; Chunfu Zhang
Journal:  Int J Nanomedicine       Date:  2014-05-21

6.  Tissue distribution and excretion kinetics of orally administered silica nanoparticles in rats.

Authors:  Jeong-A Lee; Mi-Kyung Kim; Hee-Jeong Paek; Yu-Ri Kim; Meyoung-Kon Kim; Jong-Kwon Lee; Jayoung Jeong; Soo-Jin Choi
Journal:  Int J Nanomedicine       Date:  2014-12-15

7.  Synthesis and Characterization of Encapsulated Nanosilica Particles with an Acrylic Copolymer by in Situ Emulsion Polymerization Using Thermoresponsive Nonionic Surfactant.

Authors:  Mostafa Yazdimamaghani; Tannaz Pourvala; Elaheh Motamedi; Babak Fathi; Daryoosh Vashaee; Lobat Tayebi
Journal:  Materials (Basel)       Date:  2013-08-28       Impact factor: 3.623

8.  Biodegradable mesoporous delivery system for biomineralization precursors.

Authors:  Hong-Ye Yang; Li-Na Niu; Jin-Long Sun; Xue-Qing Huang; Dan-Dan Pei; Cui Huang; Franklin R Tay
Journal:  Int J Nanomedicine       Date:  2017-01-25

9.  Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation.

Authors:  Ran You; Yuen-Shan Ho; Clara Hiu-Ling Hung; Yan Liu; Chun-Xia Huang; Hei-Nga Chan; See-Lok Ho; Sheung-Yeung Lui; Hung-Wing Li; Raymond Chuen-Chung Chang
Journal:  Part Fibre Toxicol       Date:  2018-07-03       Impact factor: 9.400

10.  Hydrophobic Mesoporous Silica Particles Modified With Nonfluorinated Alkyl Silanes.

Authors:  Chae Eun Pyo; Jeong Ho Chang
Journal:  ACS Omega       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.